The Texas Healthcare & Bioscience Institute (THBI) has announced that it will host an impressive contingency of national healthcare policy leaders and biotech CEOs at the second annual Statewide Healthcare Policy Summit. The event is taking place between February 4 and 5 during the state’s 84th Legislative Session, and several prominent biotech and life sciences leaders are already confirmed for the event.
Brett Giroir, the CEO of Texas A&M Health Science Center, Jim Greenwood, the President and CEO of Biotechnology Industry Organization (BIO), and CEO of Kalon Biotherapeutics, Andrew Strong, are three of the leaders invited to give keynotes at the Summit. Other panelists include the CEO of AdvaMed, Stephen Ubl, and the CEO of Doctors Hospital at Renaissance, Israel Rocha, Jr.
“Our guest speakers and panelists are recognized the leading national experts on healthcare and bioscience public policy,” said the president and CEO of THBI, Tom Kowalski. “We are excited that Texas has attracted such impactful people and know their remarks will set the tone for an important two-day discussion on these critical issues.”
Experts, analysts and CEOs from both national and state levels were invited to speak at the two-day Summit, which will be focused on offering insightful commentary during panel discussions and keynote sessions. The lectures will address questions like the future of Texas’ economic incentives, healthcare policies impacting the life sciences industry, and discussions with state leaders on current and future legislative priorities.
“THBI is, and always has been, the leading public policy voice for this industry in Texas,” added Tom Kowalski. “There is no other statewide conference like ours and we are excited about hosting Summit in partnership with Executive Commissioner Dr. Janek again this year.”
In addition, other speakers and panelists include Chip Davis, EVP for Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA); Patricia Hurn, Ph.D., Vice Chancellor for Research and Innovation, The University of Texas System; and Robert Robbins, M.D., President and CEO, The Texas Medical Center Corporation.
THBI also organized a Summit last June that included some of the state’s top research institutions’ leaders. Giroir and the president of MD Anderson Cancer Center, Dr. Ron DePinho, spoke at the “Steering Texas to Greatness” Summit about the context of what their research institutions are doing to contribute to the expansion of life sciences research in Texas, and where their efforts are likely to lead over the course of the next decade.